Skip to main content

Top header menu

  • Access to EMARKET SDIR
  • English
  • Italian
Home
EMARKET STORAGE - Teleborsa

Navigazione principale

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are
Menu

ALL Regulated Press Releases

Home Regulated Press releases
04/06/2021 - 08:52
DIASORIN
DiaSorin S.p.A.-Avvio programma acquisto azioni proprie
04/06/2021 - 07:05
DIASORIN
DiaSorin announces its strategic collaboration with Lumos Diagnostics
04/06/2021 - 07:05
DIASORIN
DiaSorin annuncia la collaborazione strategica con Lumos Diagnostics
03/31/2021 - 17:32
DIASORIN
Notice of availability Annual Report and related documentation
03/31/2021 - 17:31
DIASORIN
Avviso disponibilita' Relazione Finanziaria Annuale e documenti correlati
03/29/2021 - 07:02
DIASORIN
DiaSorin has obtained FDA Emergency Use Authorization for its LIAISON® SARS-CoV-2 Ag for COVID-19 testing in the U.S.
03/29/2021 - 07:02
DIASORIN
DiaSorin: il test dell’antigene LIAISON® SARS-CoV-2 Ag per la diagnosi del COVID-19 ha ricevuto l’approvazione ad uso di emergenza negli Stati Uniti
03/19/2021 - 17:37
DIASORIN
DiaSorin S.p.A. - Notice of Shareholders' Meeting April 22, 2021
03/19/2021 - 17:36
DIASORIN
DiaSorin S.p.A. - Assemblea degli Azionisti 22 aprile 2021 - Avviso di convocazione
03/11/2021 - 16:47
DIASORIN
DiaSorin S.p.A. - Dividend coupon date correction
03/11/2021 - 16:36
DIASORIN
DiaSorin S.p.A. - Rettifica data stacco dividendo
03/11/2021 - 15:37
DIASORIN
DiaSorin – Revenues, Profitability and Cash Flow Generation hit record highs in 2020
03/11/2021 - 15:36
DIASORIN
DiaSorin – Ricavi, Redditività e Generazione di Cassa Record nel 2020
01/27/2021 - 18:50
DIASORIN
DiaSorin S.p.A. - 2021 Annual Calendar of Corporate Events
01/27/2021 - 18:48
DIASORIN
DiaSorin S.p.A. - Calendario Annuale Eventi Societari 2021
01/11/2021 - 18:42
DIASORIN
DiaSorin launches with CE mark the LIAISON SARS-CoV-2 TrimericS IgG test
01/11/2021 - 18:41
DIASORIN
DiaSorin lancia con marcatura CE il LIAISON® SARS-CoV-2 TrimericS IgG
12/29/2020 - 18:22
DIASORIN
DiaSorin has received BARDA Funding in support of submitting the SIMPLEXA COVID-19 Direct Kit for 510(k) clearance
12/29/2020 - 18:20
DIASORIN
DiaSorin ha ricevuto un finanziamento dal governo americano per richiedere la certificazione 510(k) del test molecolare SIMPLEXA COVID-19 Direct
12/07/2020 - 10:35
DIASORIN
Communication on total amount of voting rights
12/07/2020 - 10:35
DIASORIN
Comunicazione ammontare complessivo diritti di voto
12/04/2020 - 16:14
DIASORIN
DiaSorin S.p.A. - Allegato 3F
12/01/2020 - 06:33
DIASORIN
DiaSorin received FDA approval for its LIAISON XL MUREX HIV Ab/Ag assay
12/01/2020 - 06:31
DIASORIN
DiaSorin ha ricevuto l’approvazione a commercializzare il test LIAISON XL MUREX HIV Ab/Ag dalla Food and Drug Administration

Pagination

  • First page « First
  • Previous page ‹ Precedente
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Current page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • …
  • Next page Seguente ›
  • Last page Last »

Footer menu

  • Disclaimer
  • Privacy
  • Cookies
  • Emergency assistance

Teleborsa - Logo

©Copyright 2022 Teleborsa S.r.l. No material on this site may be published, distributed, sold or reproduced in any form, whether printed or written, without the authorization of Teleborsa S.r.l.

  • Regulated Press releases
  • Regulated Documents
  • Support
  • Who we are